Revolution Medicines Inc. (RVMD) Prices 14M Share IPO at $17/Sh

Revolution Medicines, Inc. (NASDAQ: RVMD) today announced the pricing of its initial public offering of 14,000,000 shares of common stock at a public offering price of $17.00 per share, before underwriting discounts and commissions. All of the shares of common stock are being offered by Revolution Medicines. In addition, Revolution Medicines has granted the underwriters a 30-day option to purchase up to an additional 2,100,000 shares of common stock at the initial public offering price, less the underwriting discounts and commissions. Revolution Medicines’ common stock is expected to begin trading on the Nasdaq Global Select Market on February 13, 2020, under the ticker symbol “RVMD”. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Revolution Medicines, are expected to be approximately $238.0 million, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on February 18, 2020, subject to the satisfaction of customary closing conditions.

J.P. Morgan, Cowen, SVB Leerink and Guggenheim Securities acted as joint book-running managers for the offering.

You May Also Be Interested In

• Entrata (ENT) files for proposed IPO
• Revolution (RVMD) PT Raised to $280 at H.C. Wainwright
• NIQ Global Intelligence Plc (NIQ) PT Raised to $25 at UBS